| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLDN4 mRNA" | 25510870 |
| C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA" | 19167446 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLDN4 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLDN4 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLDN4 mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLDN4 mRNA" | 25510870 |
| C006551 | 2-amino-2-methyl-1-propanol | 2-amino-2-methyl-1-propanol results in decreased expression of CLDN4 mRNA | 25088246 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein] | 23816505 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D020106 | Acrylamide | Acrylamide affects the expression of CLDN4 mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CLDN4 mRNA | 19770486 |
| D000447 | Aldehydes | Aldehydes results in increased expression of CLDN4 mRNA | 25014914 |
| D000596 | Amino Acids | Amino Acids inhibits the reaction [Diquat results in decreased expression of CLDN4 protein] | 26338884 |
| C059765 | amphotericin B, deoxycholate drug combination | "amphotericin B, deoxycholate drug combination results in increased expression of CLDN4 mRNA" | 22863853 |
| D000872 | Anthocyanins | Anthocyanins inhibits the reaction [Cyclophosphamide results in decreased expression of CLDN4 protein] | 25451569 |
| D001151 | Arsenic | Arsenic results in increased expression of CLDN4 mRNA | 24349408 |
| D001151 | Arsenic | Arsenic results in increased expression of CLDN4 protein | 24349408 |
| D001151 | Arsenic | Arsenic affects the localization of CLDN4 protein | 24349408 |
| C006632 | arsenic trioxide | CLDN4 protein results in decreased susceptibility to arsenic trioxide | 20707922 |
| C015001 | arsenite | arsenite results in increased expression of CLDN4 mRNA | 18191166 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CLDN4 mRNA" | 25351596 |
| D001280 | Atrazine | Atrazine results in decreased expression of CLDN4 mRNA | 25929836 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CLDN4 mRNA | 20106945|2163298 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CLDN4 mRNA | 19770486 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of CLDN4 mRNA | 25566086 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of CLDN4 mRNA] | 25566086 |
| D004958 | Estradiol | Estradiol results in decreased expression of CLDN4 mRNA | 16474171 |
| D004958 | Estradiol | Estradiol results in decreased expression of CLDN4 protein | 21761342 |
| D004958 | Estradiol | Estradiol affects the expression of CLDN4 mRNA | 15598610 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CLDN4 mRNA | 16474171 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CLDN4 mRNA | 25181051 |
| D001761 | Bleomycin | Bleomycin results in increased expression of CLDN4 mRNA | 26345256 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of CLDN4 mRNA | 26079696 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CLDN4 mRNA | 25851441|2588268 |
| D002737 | Chloroprene | Chloroprene results in increased expression of CLDN4 mRNA | 23125180 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in decreased expression of CLDN4 mRNA | 25019507 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN4 mRNA | 20938992 |
| C057270 | cisplatin-DNA adduct | CLDN4 protein results in increased abundance of cisplatin-DNA adduct | 23053666 |
| D003300 | Copper | CLDN4 protein results in increased abundance of Copper | 23053666 |
| D003300 | Copper | [CLDN4 protein results in increased abundance of Copper] promotes the reaction [[TYR protein results in increased oxidation of Levodopa] which results in increased chemical synthesis of Melanins] | 23053666 |
| D003300 | Copper | [CLDN4 protein results in increased expression of SLC31A1 protein] which results in increased import of and results in increased abundance of Copper | 23053666 |
| D003300 | Copper | Copper results in increased expression of CLDN4 mRNA | 25646894 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of CLDN4 mRNA | 19549813 |
| D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA" | 19167446 |
| D003520 | Cyclophosphamide | Anthocyanins inhibits the reaction [Cyclophosphamide results in decreased expression of CLDN4 protein] | 25451569 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in decreased expression of CLDN4 protein | 25451569 |
| D003520 | Cyclophosphamide | Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of CLDN4 protein] | 25451569 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CLDN4 mRNA | 25562108|2798913 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of CLDN4 mRNA | 21865292 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CLDN4 mRNA | 21865292 |
| C007262 | deoxynivalenol | deoxynivalenol results in decreased expression of and affects the localization of CLDN4 protein | 24568843 |
| C007262 | deoxynivalenol | deoxynivalenol results in decreased expression of CLDN4 protein | 19289138|2036260 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CLDN4 mRNA | 20362602|2456884 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CLDN4 mRNA | 24568843 |
| C007262 | deoxynivalenol | deoxynivalenol analog results in decreased expression of CLDN4 protein | 22859312 |
| C007262 | deoxynivalenol | deoxynivalenol results in decreased expression of CLDN4 protein | 19289138|2285931 |
| C028009 | diallyl disulfide | diallyl disulfide results in decreased expression of CLDN4 mRNA | 20600798 |
| C028009 | diallyl disulfide | diallyl disulfide results in decreased expression of CLDN4 protein | 20600798 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in decreased expression of CLDN4 mRNA | 24084732 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in decreased expression of CLDN4 protein | 24084732 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of CLDN4 mRNA | 24893172 |
| D002945 | Cisplatin | [CLDN4 protein results in increased expression of SLC31A1 protein] which results in increased import of Cisplatin | 23053666 |
| D002945 | Cisplatin | CLDN4 protein results in increased import of Cisplatin | 23053666 |
| D002945 | Cisplatin | CLDN4 protein results in increased susceptibility to Cisplatin | 23053666 |
| C121718 | dicyclanil | dicyclanil results in increased expression of CLDN4 mRNA | 15664270 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of CLDN4 mRNA | 26924002 |
| D002117 | Calcitriol | Calcitriol results in increased expression of CLDN4 mRNA | 26485663 |
| C024629 | dimethyl phthalate | dimethyl phthalate affects the expression of CLDN4 mRNA | 26924002 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D004178 | Diquat | Amino Acids inhibits the reaction [Diquat results in decreased expression of CLDN4 protein] | 26338884 |
| D004178 | Diquat | Diquat results in decreased expression of CLDN4 protein | 26338884 |
| D007980 | Levodopa | [CLDN4 protein results in increased abundance of Copper] promotes the reaction [[TYR protein results in increased oxidation of Levodopa] which results in increased chemical synthesis of Melanins] | 23053666 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of CLDN4 mRNA | 15033991 |
| D000431 | Ethanol | Ethanol results in decreased expression of and affects the localization of CLDN4 protein | 28412402 |
| D000431 | Ethanol | Flavonoids inhibits the reaction [Ethanol affects the localization of CLDN4 protein] | 28412402 |
| D000431 | Ethanol | Flavonoids inhibits the reaction [Ethanol results in decreased expression of and affects the localization of CLDN4 protein] | 28412402 |
| D000431 | Ethanol | Plant Extracts inhibits the reaction [Ethanol results in decreased expression of and affects the localization of CLDN4 protein] | 28412402 |
| D000431 | Ethanol | Ethanol results in decreased expression of CLDN4 mRNA | 28069986 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CLDN4 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLDN4 mRNA | 17942748 |
| D005419 | Flavonoids | Flavonoids inhibits the reaction [Ethanol affects the localization of CLDN4 protein] | 28412402 |
| D005419 | Flavonoids | Flavonoids inhibits the reaction [Ethanol results in decreased expression of and affects the localization of CLDN4 protein] | 28412402 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of CLDN4 mRNA | 17187413 |
| D005472 | Fluorouracil | CLDN4 protein affects the susceptibility to Fluorouracil | 15352031 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of CLDN4 protein | 15352031 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN4 mRNA | 20938992 |
| C056933 | fumonisin B1 | fumonisin B1 results in decreased expression of CLDN4 mRNA | 27153755 |
| C056933 | fumonisin B1 | illite inhibits the reaction [fumonisin B1 results in decreased expression of CLDN4 mRNA] | 27153755 |
| C039281 | furan | furan results in increased expression of CLDN4 mRNA | 26194646|2738771 |
| D019833 | Genistein | Genistein results in decreased expression of CLDN4 mRNA | 16474171 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein] | 23816505 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D017313 | Fenretinide | Fenretinide results in increased expression of CLDN4 mRNA | 16671099 |
| D017313 | Fenretinide | Fenretinide results in increased expression of CLDN4 mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein] | 23816505 |
| D006861 | Hydrogen Peroxide | Glutathione inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein] | 23816505 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CLDN4 protein | 23816505 |
| D006861 | Hydrogen Peroxide | pyrazolanthrone inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein] | 23816505 |
| D006861 | Hydrogen Peroxide | U 0126 inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein] | 23816505 |
| C099089 | illite | illite affects the reaction [ochratoxin A results in decreased expression of CLDN4 mRNA] | 27153755 |
| C099089 | illite | illite inhibits the reaction [fumonisin B1 results in decreased expression of CLDN4 mRNA] | 27153755 |
| C099089 | illite | illite inhibits the reaction [T-2 Toxin results in decreased expression of CLDN4 mRNA] | 27153755 |
| C051140 | iron(II)-ascorbic acid complex | iron(II)-ascorbic acid complex affects the localization of CLDN4 protein | 19540330 |
| D016729 | Leuprolide | Leuprolide results in decreased expression of CLDN4 protein | 21761342 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D008353 | Mannitol | Mannitol results in increased expression of CLDN4 protein | 23816505 |
| D019290 | Megestrol Acetate | Megestrol Acetate results in decreased expression of and results in increased localization of CLDN4 protein | 23095775 |
| D019290 | Megestrol Acetate | Megestrol Acetate results in decreased expression of CLDN4 mRNA | 23095775 |
| D008543 | Melanins | [CLDN4 protein results in increased abundance of Copper] promotes the reaction [[TYR protein results in increased oxidation of Levodopa] which results in increased chemical synthesis of Melanins] | 23053666 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of CLDN4 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN4 mRNA | 20938992 |
| D008727 | Methotrexate | Methotrexate results in increased expression of CLDN4 mRNA | 21678067 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in increased expression of CLDN4 mRNA | 24810058 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Progesterone results in decreased expression of CLDN4 protein] | 17478549 |
| C028577 | monobutyl phthalate | monobutyl phthalate results in increased expression of CLDN4 mRNA | 29162477 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of CLDN4 mRNA | 26924002 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog affects the expression of CLDN4 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CLDN4 mRNA" | 25554681 |
| C031721 | naphthalene | naphthalene results in increased expression of CLDN4 mRNA | 18978301 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of CLDN4 mRNA | 20551477 |
| C025589 | ochratoxin A | illite affects the reaction [ochratoxin A results in decreased expression of CLDN4 mRNA] | 27153755 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of CLDN4 mRNA | 27153755 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of CLDN4 mRNA | 26272509 |
| D010365 | Patulin | Patulin affects the localization of CLDN4 protein | 19013514 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLDN4 mRNA" | 25510870 |
| C046012 | pentanal | pentanal results in increased expression of CLDN4 mRNA | 26079696 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of CLDN4 mRNA | 26272509 |
| D010705 | Phosgene | Phosgene affects the expression of CLDN4 mRNA | 16300373 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of CLDN4 mRNA | 17426115 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Ethanol results in decreased expression of and affects the localization of CLDN4 protein] | 28412402 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of CLDN4 protein] | 25451569 |
| D028321 | Plant Preparations | Plant Preparations results in decreased expression of CLDN4 mRNA | 26945725 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls analog results in decreased expression of CLDN4 mRNA | 16474171 |
| D011374 | Progesterone | Progesterone results in decreased expression of CLDN4 mRNA | 18037150 |
| D011374 | Progesterone | Progesterone affects the expression of CLDN4 mRNA | 17251523 |
| D011374 | Progesterone | Mifepristone inhibits the reaction [Progesterone results in decreased expression of CLDN4 protein] | 17478549 |
| D011374 | Progesterone | Progesterone results in decreased expression of CLDN4 protein | 17478549 |
| C005556 | propionaldehyde | propionaldehyde results in decreased expression of CLDN4 mRNA | 26079696 |
| C005556 | propionaldehyde | propionaldehyde results in increased expression of CLDN4 mRNA | 26079696 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein] | 23816505 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D011794 | Quercetin | Quercetin results in increased expression of and affects the localization of CLDN4 protein | 19297429 |
| D011794 | Quercetin | Quercetin results in increased expression of CLDN4 mRNA | 18492835 |
| D011794 | Quercetin | Quercetin results in increased expression of CLDN4 protein | 18492835 |
| D011794 | Quercetin | Quercetin results in decreased expression of CLDN4 mRNA | 28431985 |
| D011794 | Quercetin | Quercetin results in decreased expression of CLDN4 protein | 28431985 |
| C012526 | quercitrin | quercitrin affects the expression of CLDN4 mRNA | 25193878 |
| C085746 | rottlerin | rottlerin results in increased expression of and affects the localization of CLDN4 protein | 19297429 |
| C005705 | sanguinarine | sanguinarine results in decreased expression of CLDN4 protein | 19063874 |
| D012643 | Selenium | Selenium results in increased expression of CLDN4 mRNA | 19244175 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CLDN4 mRNA | 25351596 |
| D012906 | Smoke | Smoke results in decreased expression of CLDN4 mRNA | 21095227 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CLDN4 mRNA | 12634122 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CLDN4 mRNA | 24349408 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CLDN4 protein | 24349408 |
| C017947 | sodium arsenite | sodium arsenite affects the localization of CLDN4 protein | 24349408 |
| D012965 | Sodium Chloride | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | Sodium Chloride results in increased expression of CLDN4 protein | 23816505 |
| D012965 | Sodium Chloride | U 0126 inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| D012965 | Sodium Chloride | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| D012965 | Sodium Chloride | diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| D012965 | Sodium Chloride | Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| D012965 | Sodium Chloride | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| D012965 | Sodium Chloride | pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D012965 | Sodium Chloride | Sodium Chloride results in increased expression of CLDN4 mRNA | 23816505 |
| D012965 | Sodium Chloride | Sodium Chloride results in increased expression of CLDN4 protein | 23816505 |
| D012965 | Sodium Chloride | [[SP1 protein co-treated with JUN protein] binds to CLDN4 promoter] promotes the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505|2381650 |
| D012965 | Sodium Chloride | U 0126 inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| D012965 | Sodium Chloride | U 0126 inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D053260 | Soot | Soot results in increased expression of CLDN4 mRNA | 26551751 |
| D013605 | T-2 Toxin | illite inhibits the reaction [T-2 Toxin results in decreased expression of CLDN4 mRNA] | 27153755 |
| D013605 | T-2 Toxin | T-2 Toxin results in decreased expression of CLDN4 mRNA | 27153755 |
| D016559 | Tacrolimus | Tacrolimus results in increased expression of CLDN4 mRNA | 21865292 |
| D013629 | Tamoxifen | CLDN4 affects the susceptibility to Tamoxifen | 19142967 |
| D013739 | Testosterone | Testosterone deficiency results in decreased expression of CLDN4 mRNA | 21761342 |
| D013739 | Testosterone | Testosterone affects the expression of CLDN4 protein | 21761342 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CLDN4 mRNA | 20055451 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CLDN4 mRNA | 21570461|2637764 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLDN4 mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CLDN4 mRNA | 17942748 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of CLDN4 mRNA | 19945525 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of CLDN4 mRNA | 19945525 |
| D013792 | Thalidomide | Thalidomide results in increased expression of CLDN4 mRNA | 26217789 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of CLDN4 mRNA | 23131501 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CLDN4 mRNA | 27404394 |
| C496197 | trans-10,cis-12-conjugated linoleic acid | "trans-10,cis-12-conjugated linoleic acid results in increased expression of CLDN4 mRNA" | 16650747|1795147 |
| D014212 | Tretinoin | CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN4 mRNA] | 17035595 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CLDN4 mRNA | 17035595 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CLDN4 protein | 17035595 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CLDN4 mRNA | 16236135 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CLDN4 mRNA | 20488242 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CLDN4 mRNA | 24935251|2627250 |
| C057693 | troglitazone | troglitazone results in increased expression of CLDN4 mRNA | 19285010 |
| C057693 | troglitazone | troglitazone results in increased expression of CLDN4 protein | 19285010 |
| D014415 | Tunicamycin | Tunicamycin results in increased expression of CLDN4 mRNA | 17127020 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein] | 23816505 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| C113580 | U 0126 | U 0126 results in increased expression of CLDN4 mRNA | 19285010 |
| C113580 | U 0126 | U 0126 results in increased expression of CLDN4 protein | 19285010 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA] | 23816505 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] | 23816505 |
| D014508 | Urea | Urea results in increased expression of CLDN4 protein | 23816505 |
| D014520 | Urethane | Urethane results in increased expression of CLDN4 mRNA | 28818685 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of CLDN4 mRNA | 23179753|2438349 |
| C034028 | vanadyl sulfate | vanadyl sulfate results in increased expression of CLDN4 mRNA | 16330358 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of CLDN4 gene | 25560391 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA" | 27188386 |
| D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical affects the expression of CLDN4 mRNA" | 25208076 |